F-14/15, Orbit Mall, Civil Lines, Jaipur-302006
support@thetaxheaven.com
F-14/15, Orbit Mall, Civil Lines, Jaipur-302006 support@thetaxheaven.comProcter and Gamble Hygiene and Health Care Ltd, a renowned subsidiary of the global FMCG leader Procter & Gamble, is among India’s top health and hygiene product manufacturers. With a solid brand portfolio including Whisper and Vicks, the company holds a strong market position. In this article, we explore the Procter and Gamble Hygiene and Health Care Ltd share price target from 2025 to 2030, based on financial insights, stock data, and market trends.
Let’s take a look at its latest performance and forecast for the upcoming years.
| Detail | Value |
|---|---|
| Current Price | ₹13,196.00 |
| Open | ₹13,266.00 |
| Day’s High / Low | ₹13,374.00 / ₹13,164.00 |
| VWAP | ₹13,237.20 |
| Market Capitalization | ₹42,831 Cr |
| Beta (Volatility) | 0.26 |
| 52-Week High / Low | ₹17,745.00 / ₹12,105.60 |
| All-Time High / Low | ₹19,250.00 / ₹355.00 |
| Book Value Per Share | ₹303.99 |
| Face Value | ₹10 |
| 20D Avg Volume / Delivery | 8,386 / 63.93% |
Founded with a mission to improve lives through innovative hygiene and healthcare solutions, Procter and Gamble Hygiene operates in India under the NSE and BSE. With global backing and strong distribution, it delivers products with high consumer loyalty. The company focuses on sustained growth through brand leadership, product innovation, and efficient operations.
Backed by global giant Procter & Gamble (P&G)
Operates in health and hygiene FMCG segment
Strong consumer loyalty for core brands like Vicks, Whisper, and Oral-B
Low beta indicates price stability, ideal for long-term investors
High promoter holding reflects trust in company fundamentals
| Investor Type | Holding (%) |
|---|---|
| Promoters | 70.64% |
| Retail & Others | 12.52% |
| Mutual Funds | 8.26% |
| Domestic Institutions | 7.24% |
| Foreign Institutions | 1.33% |
The shareholding pattern indicates strong promoter confidence and steady institutional interest, making it a stable investment for long-term portfolios.
| Year | Minimum Target (₹) | Maximum Target (₹) |
|---|---|---|
| 2025 | ₹14,000 | ₹15,500 |
| 2026 | ₹15,800 | ₹17,200 |
| 2027 | ₹17,500 | ₹19,000 |
| 2028 | ₹18,800 | ₹21,000 |
| 2029 | ₹20,000 | ₹22,500 |
| 2030 | ₹21,500 | ₹24,000 |
These share price targets from 2025 to 2030 are based on adjusted earnings growth, volume trends, and industry forecasts. With steady financial performance and low volatility, Procter & Gamble Hygiene stock shows promising potential in the Indian share market.
In 2025, the company is expected to benefit from increased rural penetration and strong brand loyalty. Backed by inflation moderation and stable input costs, the target for 2025 reflects optimism around rising demand in the health and hygiene sector.
Investment Advice: Ideal for investors seeking price stability and consistent returns in FMCG.
The 2026 target price shows an expected rise due to product expansion, cost efficiencies, and favorable macroeconomic conditions. The stock may see a gradual upward trend throughout the year.
Investment Advice: A good year to hold or increase exposure during dips.
By 2027, the stock is likely to touch new highs as the company continues investing in digital transformation and efficiency. Innovations in hygiene product lines will further support growth.
Investment Advice: Reinvest dividends and maintain a long-term outlook.
In 2028, public awareness around hygiene and health will drive product demand. The company is expected to see expansion in Tier 2 and Tier 3 cities, boosting revenue and stock performance.
Investment Advice: Hold for long-term capital appreciation.
By 2029, the company may benefit from global supply chain integration and cross-border sales. This could lead to enhanced valuation and premium pricing in the Indian share market.
Investment Advice: Suitable for investors with medium- to long-term goals.
The stock may cross ₹24,000 by end of 2030 if current market trends and profitability continue. The company's low debt, consistent returns, and brand strength suggest long-term reliability.
Investment Advice: Continue investing through SIPs or staggered buying for wealth creation.
Yes. If you're looking for a low-risk, fundamentally strong stock in the FMCG health segment, this is a solid candidate.
High promoter holding ensures stability
Low beta stock = low volatility
Consistent revenue and net profit growth
Ideal for defensive, long-term portfolios
Q1: What is the Procter & Gamble Hygiene share price target for 2025?
A: Between ₹14,000 and ₹15,500 depending on market conditions and demand growth.
Q2: Will the share price reach ₹24,000 by 2030?
A: Based on historical growth and market trends, it may touch ₹24,000 if the company maintains operational performance.
Q3: Is Procter & Gamble Hygiene a safe investment?
A: Yes, with low beta and high promoter holding, it’s suitable for conservative investors.
Q4: How does this stock compare with other FMCG players?
A: It performs strongly in its niche—health and hygiene—with limited competition and high brand trust.
Q5: Should I buy at current levels?
A: Investors with a 5+ year horizon can consider staggered buying or SIPs.
Procter and Gamble Hygiene and Health Care Ltd is a stable and fundamentally sound FMCG stock with a strong growth outlook. With the share price target projected to reach ₹24,000 by 2030, long-term investors can benefit from consistent returns, dividend payouts, and strong brand equity. As always, consult your financial advisor before making any investment decisions.
Disclaimer: This blog is for informational purposes only. Please do your own research or consult a SEBI-registered advisor before investing.
Register & Login